Skip to main content
. 2022 Jun 16;150(2):312–324. doi: 10.1016/j.jaci.2022.05.019

Fig 5.

Fig 5

A and B, Dot plot displaying the effect size (ES) of severe versus mild COVID-19 (x-axis) against the ES of the indicated comorbidity versus without the indicated comorbidity (y-axis). Each dot represents 1 immunologic feature, colored for the affected immune compartment. The black box highlights immune features for further in-depth analysis. C-F, The median expression and 25th and 75th percentiles of the indicated parameters in the indicated FlowSOM-generated immune cell clusters. Comparison of patients with HD, patients with no HD, and healthy controls (C-E), and patients with an LAD, patients with no LAD, and healthy controls (F). ∗P < .05; ∗∗P < .01; ∗∗∗P < .001; ∗∗∗∗P < .0001; Mann-Whitney test and Benjamini-Hochberg correction.